◆ 会议时间：2025年8月24-27日
◆ 会议地点：加拿大 渥太华

◆ 会议简介：

2025年世界结节病和其它肉芽肿病协会(WASOG)/美国结节病及其他肉芽肿性疾病协会(AASOG)联合大会将于2025年8月24-27日在加拿大渥太华举行。

世界结节病和其它肉芽肿病协会(WASOG)是代表世界结节病和其他肉芽肿病协会的组织，于1987年由意大利米兰的Geraint James博士在世界肉芽肿病大会期间发起成立。WASOG关注的重点是间质性肺病（ILD），包括结节病；致力于通过提供信息、教育宣和最先进的研究，完善和优化患者的护理，提高医师的知识水平。WASOG成员来自世界各地，包括肺科医生，心心脏病学家、皮肤病学家、神经病学家、传染病专家、肝病学家、遗传学家和血液学家。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

WASOG/AASOG 2025
World Association for Sarcoidosis and Other Granulomatous Disorders (WASOG) & Americas Association of Sarcoidosis and Other Granulomatous Disorders (AASOG) Conference 

Date: August 24-27, 2025
Venue: Ottawa, Canada

摘要征文投稿：

Abstract Submission Deadline: February 16, 2025

点此提交摘要>>>Submit Abstract>>>

FEE
There is no fee to submit an abstract.

CONFIRMATION
Abstracts must be submitted through the online abstract submission platform. Submission by any other means, such as mail or email, will not be accepted. Do not make multiple submissions of the same abstract. A confirmation with the abstract reference number will automatically be sent to the email address of the submitter. If after submitting an abstract you cannot find this email, please check your spam/junk folder.

PUBLICATION AGREEMENT
Authors of accepted abstracts agree to make their abstract(s) available on the conference website and mobile application. Authors who do not wish to make their abstract available on the website must notify the conference secretariat: wasog2025@intertaskconferences.com.

PRESENTATION AND PUBLICATION ELIGILITY
To be eligible to display a poster at the conference and to have your abstract included in the digital publication, the presenting author must register to attend the WASOG/AASOG 2025 Conference and pay any associated registration fees. All costs associated with travel to the conference location, lodging and meals are the sole responsibility of the presenting author. Authors not registered by May 15, 2025 may have their abstract withdrawn.

DEADLINE
Submissions must be received electronically through the online submission form no later than Sunday, February 16, 2025, 23:30 ET. Late or mailed submissions will not be accepted. Submitters may return and edit their submissions until the deadline.

LANGUAGE
Abstracts must be submitted in English. Please note that all conference sessions (including oral presentations) will be conducted in English.

ABSTRACT FORMAT
The maximum number of words is 400. Title, authors, reference and tables/images will NOT be counted. Only one table OR one image may be uploaded.

• Submission of an abstract constitutes a commitment by the author(s) to present their work.
• There is no limit to the number of abstracts an individual may submit.
• A submitter should not “split” data to create several abstracts from one. If splitting is judged to have occurred, scores of related abstracts will be reduced.
• Abstracts containing identical or nearly identical data submitted from the same institution and/or individuals may be disqualified.
• Abstracts with no data or incomplete data will receive a score of zero (0).

ANONYMITY
Only FULLY ANONYMOUS abstracts or case reports/series will be accepted for review. No identification of authors, institution of origin, geographic area, sources of funding, or author references may appear in the Title or Text. For example, do not state ‘the study was approved by the University of Ottawa REB’, rather, ‘Local Ethics Committee approval was obtained’.

All submissions MUST identify a presenting author, and the maximum presenters per abstract is one (1).

All correspondence will be sent to the submitter. It is their responsibility to communicate this information to any additional authors.

PRESENTATION FORMAT
All abstracts attaining the minimal passing score, will be invited to display a poster at the WASOG/AASOG 2025 Conference in Ottawa, Canada. Top scoring abstracts may be invited to also give a short oral presentation. All abstracts and poster will be published digitally on the Abstract site.

JUDGING
All abstracts will undergo a blinded review process by the WASOG/AASOG Scientific Program Committee. Authors should be careful to avoid submitting multiple datasets from one study as multiple abstracts. Multiple submissions from a single study or dataset will be excluded unless prior clarification and approval is provided. Abstracts with no data or incomplete data will be disqualified.

CONFLICT OF INTEREST DISCLOSURE
ALL authors of accepted abstracts will be required to submit a conflict of interest disclosure for inclusion in the final program after the judging process is complete. Requirements will be detailed within notification of acceptance, which will be emailed on or around March 24, 2025 to the submitter. Conflict of interest declarations must be completed by April 15, 2025 and presenting author registration no later than May 15, 2025.

We are excited to invite you to the WASOG/AASOG 2025 Conference in the heart of Canada's capital, Ottawa, a vibrant city rich with history, culture, and beautiful landscapes. This international event brings together leading experts, researchers, healthcare professionals, and advocates to discuss the latest advancements in the diagnosis, treatment, and management of sarcoidosis and other granulomatous disorders.

Why Attend?

• Cutting-Edge Research: Stay ahead with insights on groundbreaking research, emerging treatments, and innovative approaches to managing these rare diseases.
• Global Networking: Connect with professionals from around the world, share knowledge, and foster collaborations that can lead to future advancements.
• Expert Panels: Learn from top specialists in the field through interactive sessions and thought-provoking panel discussions.
• Patient-Centered Focus: Discover the latest in patient care strategies and how to improve quality of life for those affected by sarcoidosis and related conditions.

Explore Ottawa’s stunning architecture, rich heritage, and renowned hospitality while attending a conference that promises to shape the future of sarcoidosis and granulomatous disorder research and treatment.

Don’t miss this unique opportunity to contribute to the global conversation on sarcoidosis and granulomatous disorders. Whether you're a clinician, researcher, or patient advocate, this is an event you won’t want to miss!

Together, let’s drive progress in the fight against sarcoidosis and other granulomatous disorders.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。